Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review

November 2021 | 49 pages | ID: RFF0EBC512DEN
GlobalData

Abstracts

Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Recro Pharma Inc (Recro) provides contract development and manufacturing organization (CDMO) services. The company harnesses formulation capabilities and proprietary delivery technologies for the development, manufacture, and commercialization of pharmaceutical products of its partners. The company manufactures products such as Ritalin LA, Focalin XR, Verelan PM, Verelan SR, and Zohydro ER among others for its commercial partners. The company has a manufacturing facility in Gainesville, Georgia, the US. Recro Pharma is headquartered in Malvern, Pennsylvania, the US.

Recro Pharma Inc Key Recent Developments

Nov 09,2021: Recro Reports Third Quarter 2021 Financial Results
Nov 02,2021: Recro 3Q 2021 Earnings Call
Oct 27,2021: Recro enters into master commercial supply and services agreement with Otsuka
Oct 06,2021: Recro Reports Inducement Grants For New StaffHighlights Appointment of New Vice President and Site Head of Operations for Recro San Diego
Aug 09,2021: Recro Reports Second Quarter 2021 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Recro Pharma Inc - Key Facts
Recro Pharma Inc - Key Employees
Recro Pharma Inc - Key Employee Biographies
Recro Pharma Inc - Major Products and Services
Recro Pharma Inc - History
Recro Pharma Inc - Company Statement
Recro Pharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Recro Pharma Inc - Business Description
Recro Pharma Inc - Corporate Strategy
Recro Pharma Inc - SWOT Analysis
SWOT Analysis - Overview
Recro Pharma Inc - Strengths
Recro Pharma Inc - Weaknesses
Recro Pharma Inc - Opportunities
Recro Pharma Inc - Threats
Recro Pharma Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recro Pharma Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 09, 2021: Recro Reports Third Quarter 2021 Financial Results
Nov 02, 2021: Recro 3Q 2021 Earnings Call
Oct 27, 2021: Recro enters into master commercial supply and services agreement with Otsuka
Oct 06, 2021: Recro Reports Inducement Grants For New StaffHighlights Appointment of New Vice President and Site Head of Operations for Recro San Diego
Aug 09, 2021: Recro Reports Second Quarter 2021 Financial Results
Jul 20, 2021: Recro Appoints Erica Raether as Vice President of People, Culture and ESG
Jun 16, 2021: Recro Appoints Laura L. Parks, Ph.D. to Board of Directors
Jun 02, 2021: Recro expands capabilities for growing clinical trial services (CTS) offerings
May 06, 2021: Recro Reports First Quarter 2021 Financial Results
Apr 29, 2021: Recro to Report Financial Results for First Quarter 2021 on May

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Recro Pharma Inc, Key Facts
Recro Pharma Inc, Key Employees
Recro Pharma Inc, Key Employee Biographies
Recro Pharma Inc, Major Products and Services
Recro Pharma Inc, History
Recro Pharma Inc, Subsidiaries
Recro Pharma Inc, Key Competitors
Recro Pharma Inc, Ratios based on current share price
Recro Pharma Inc, Annual Ratios
Recro Pharma Inc, Annual Ratios (Cont...1)
Recro Pharma Inc, Annual Ratios (Cont...2)
Recro Pharma Inc, Interim Ratios
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recro Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Recro Pharma Inc, Performance Chart (2016 - 2020)
Recro Pharma Inc, Ratio Charts
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recro Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021